 KEPPRA
|
GlaxoSmithKline Biopharma
|
| levetiracetam |
Antiepiléptico |
| 1000 mg comp.x 30 | $164.177,72 | (30/04/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $80.479,27 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $47.995,01 AF $116.182,71 |
|
|
|
|
| 1000 mg comp.x 60 | $224.000,31 | (30/04/25) |
| Importado |
| PAMI |
|
| AF $89.105,45 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $76.507,27 AF $147.493,04 |
|
|
|
|
| 500 mg comp.x 20 | $68.819,14 | (30/04/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $30.732,78 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $29.990,26 AF $38.828,88 |
|
|
|
|
| 500 mg comp.x 30 | $78.462,92 | (30/04/25) |
| Importado |
| PAMI |
|
| AF $32.035,53 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $47.995,01 AF $30.467,91 |
|
|
|
|
| 500 mg comp.x 60 | $153.908,46 | (30/04/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $75.445,32 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $76.507,27 AF $77.401,19 |
|
|
|
|
| sol.oral x 300 ml | $206.095,15 | (30/04/25) |
| Importado |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $88.234,26 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $92.837,80 AF $113.257,35 |
|
|
|
|
| |
